ClinicalTrials.gg
CompletedNCT02632110Updated Jan 18, 2018Results posted

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

A Phase 2 interventional study of ALA and Topical Solution Vehicle in Actinic Keratosis, sponsored by DUSA Pharmaceuticals, Inc.. Completed at 8 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-01-18.

Sponsored by DUSA Pharmaceuticals, Inc. (part of Sun Pharmaceutical Industries Limited) · Phase 2, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
137
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 29 studies testing Aminolevulinic Acid in Keratosis, Actinic — 1 open to participants now, 2 under way, none of them phase 3. Aminolevulinic Acid · Keratosis, Actinic.

Enrollment
7th of 29
137 · median 32
Started
2016
with 1 other
Phase 2
11 of 29
none open now
Registered
16th of 29
by date
Lead sponsor
9 of 29
DUSA Pharmaceuticals, Inc.

Among the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic, this one is the 7th largest by enrollment, is one of 2 that started in 2016, is one of 11 in phase 2, and was the 16th registered.

Keratosis, Actinic

343 studies on the registry are indexed under Keratosis, Actinic; 29 are open to participants now.

Browse Keratosis, Actinic studies →

Open to participants now

1 of the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

About Aminolevulinic Acid

Aminolevulinic Acid: first FDA approval 1999 (LEVULAN), first EMA approval 2007. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 21 Keratosis, Actinic studies recruiting now, 16 (76%) set no upper age limit and 1 (5%) stops at 75 or younger; none take children under 18; 2 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies testing Aminolevulinic Acid in Keratosis, Actinic, or all of them as a file.
02

Study summary

The purpose of this study is to determine the viability of microneedle lesion preparation (MN) to enhance treatment benefit when performed prior to ALA PDT to an actinic keratosis (AK) field on the face.

03

Conditions studied

  • Actinic Keratosis

Browse trials for

Keywords

  • Actinic Keratosis
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Four to eight AKs on the face

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • history of cutaneous photosensitization, porphyria, to porphyrins or photodermatosis
  • lesions suspicious for skin cancer (skin cancer not ruled out by ) or untreated skin cancers within the Treatment Area
  • skin pathology or condition which could interfere with the evaluation of the test product or requires the use of interfering topical or systemic therapy
  • Subject is
  • currently enrolled in an drug or device study
  • has received an investigational drug or been treated with an investigational device within 30 days prior to the initiation of treatment
  • known sensitivity to one or more of the vehicle components (ethyl alcohol, isopropyl alcohol, laureth 4, polyethylene glycol)
  • has an active herpes simplex infection OR a history of 2 or more outbreaks within the past 12 months, on the face
  • use of the following topical preparations on the extremity to be treated:

    • Keratolytics including urea (greater than 5%), alpha hydroxyacids [e.g.glycolic acid, lactic acid, etc. greater than 5%], salicylic acid (greater than 2%) within 2 days
    • Curettage or Cryotherapy within 2 weeks of initiation of treatment
    • Retinoids, including tazarotene, adapalene, tretinoin, within 4 weeks
    • Microdermabrasion, laser ablative treatments, ALA-PDT, chemical peels, 5 fluorouracil, diclofenac, ingenol mebutate, imiquimod or other topical treatments for AK within 8 weeks
  • use of systemic retinoid therapy within 6 months
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
137 participants (actual)

Study arms

  • Experimental
    ALA 25 min 10 Milliwatts (mW)

    ALA-PDT, 25 min incubation period, 10 mW/cm2 power density for 16 min 40 second light treatment.

    Drug: ALA · Device: IBL 10 mW

  • Experimental
    MN + ALA 25 min 10 mW

    Microneedle lesion preparation prior to ALA-PDT, 25 min incubation period, 10 mW/cm2 power density for 16 min 40 second light treatment.

    Drug: ALA · Device: IBL 10 mW · Procedure: Microneedle lesion preparation

  • Experimental
    ALA 25 min 20 mW

    ALA-PDT, 25 min incubation period, 20 mW/cm2 power density for 8 min 20 second light treatment.

    Drug: ALA · Device: IBL 20 mW

  • Experimental
    MN + ALA 25 min 20 mW

    Microneedle lesion preparation prior to ALA-PDT, 25 min incubation period, 20 mW/cm2 power density for 8 min 20 second light treatment.

    Drug: ALA · Procedure: Microneedle lesion preparation · Device: IBL 20 mW

  • Experimental
    ALA 60 min 10 mW

    ALA-PDT, 60 min incubation period, 10 mW/cm2 power density for 16 min 40 second light treatment.

    Drug: ALA · Device: IBL 10 mW

  • Experimental
    MN + ALA 60 min 10 mW

    Microneedle lesion preparation prior to ALA-PDT, 60 min incubation period, 10 mW/cm2 power density for 16 min 40 second light treatment.

    Drug: ALA · Device: IBL 10 mW · Procedure: Microneedle lesion preparation

  • Experimental
    ALA 60 min 20 mW

    ALA-PDT, 60 min incubation period, 20 mW/cm2 power density for 8 min 20 second light treatment.

    Drug: ALA · Device: IBL 20 mW

  • Experimental
    MN + ALA 60 min 20 mW

    Microneedle lesion preparation prior to ALA-PDT, 60 min incubation period, 20 mW/cm2 power density for 8 min 20 second light treatment.

    Drug: ALA · Procedure: Microneedle lesion preparation · Device: IBL 20 mW

  • Placebo comparator
    VEH

    Vehicle (VEH) PDT, 60 minute incubation period, 10 mW/cm2 power density for 16 min 40 second light treatment.

    Drug: Topical Solution Vehicle · Device: IBL 10 mW

  • Placebo comparator
    MN + VEH

    Microneedle lesion preparation prior to Vehicle PDT, 60 minute incubation period, 10 mW/cm2 power density for 16 min 40 second light treatment.

    Drug: Topical Solution Vehicle · Device: IBL 10 mW · Procedure: Microneedle lesion preparation

Interventions

  • DrugALA

    20% ALA applied to face prior to light treatment

    Also known as: Levulan Kerastick, Aminolevulinic acid

  • DrugTopical Solution Vehicle

    Levulan Kerastick containing vehicle ingredients only. Vehicle solution applied to face prior to light treatment

  • DeviceIBL 10 mW

    10 J/cm2 blue light delivered at 10 mW/cm2 for 16 minutes 40 seconds

    Also known as: Investigational Blue Light (IBL)

  • ProcedureMicroneedle lesion preparation

    Microneedling of all visible/palpable AK lesions prior to solution application.

  • DeviceIBL 20 mW

    10 J/cm2 blue light delivered at 20 mW/cm2 for 8 minutes 20 seconds

    Also known as: Investigational Blue Light

06

What researchers measure

Primary outcomes

  1. Complete Clearance Rate

    Number of AK Fields with 0 lesions

    Time frame: Week 12

Secondary outcomes

  1. Complete Clearance Rate

    Number of AK Fields with 0 Lesions

    Time frame: Week 8

  2. Subject Satisfaction Score

    Subject satisfaction score 1. = Excellent (very satisfied) 2. = Good (moderately satisfied) 3. = Fair (slightly satisfied) 4. = Poor (not satisfied at all)

    Time frame: Week 12

  3. Baseline AKCR

    AK clearance rate (AKCR) for only those lesions present at Baseline

    Time frame: Baseline and Week 8

  4. Baseline AKCR

    AK clearance rate for only those lesions present at Baseline

    Time frame: Baseline and Week 12

  5. Percent Change

    Percent change in the total AK number as compared with Baseline

    Time frame: Baseline and Week 8

  6. Percent Change

    Percent change in the total AK number as compared with Baseline

    Time frame: Baseline and Week 12

Other outcomes

  1. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: Baseline

  2. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 24-48 hours after PDT #1

  3. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 2 Weeks after PDT #1

  4. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 8 Weeks after PDT #1

  5. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 12 Weeks after PDT #1

  6. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: Baseline

  7. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: 24-48 hours after PDT #1

  8. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: 2 Weeks after PDT #1

  9. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: 8 Weeks after PDT #1

  10. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: 12 Weeks after PDT #1

  11. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: Baseline

  12. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 5 minutes after PDT #1

  13. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 24-48 hours after PDT #1

  14. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 2 Weeks after PDT #1

  15. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 8 Weeks after PDT #1

  16. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 12 Weeks after PDT #1

  17. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: Baseline

  18. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 5 minutes after PDT #1

  19. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 24-48 hours after PDT #1

  20. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 2 weeks after PDT #1

  21. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 8 Weeks after PDT #1

  22. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 12 Weeks after PDT #1

  23. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: Baseline

  24. Stinging/Burning

    Immediately after PDT, the most intensive, acute perception of Stinging/Burning DURING treatment will be recorded. STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: During PDT #1

  25. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 5 minutes after PDT #1

  26. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 24-48 Hours after PDT #1

  27. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 2 Weeks after PDT #1

  28. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 8 Weeks after PDT #1

  29. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 12 Weeks after PDT #1

  30. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: Baseline

  31. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 24-48 hours after PDT #1

  32. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 2 Weeks after PDT #1

  33. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 8 Weeks after PDT #1

  34. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 12 Weeks after PDT #1

  35. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: Baseline

  36. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 24-48 hours after PDT #1

  37. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 2 Weeks after PDT #1

  38. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 8 Weeks after PDT #1

  39. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 12 Weeks after PDT #1

07

Results

Posted Dec 13, 2017

Participant flow

Participant flow — Overall Study
MilestoneMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEH 60 Min 10 mWVEH 60 Min 10 mW
Started25252727292926263030
Completed24242727282823232929
Not completed1100113311
Withdrew: Withdrawal by subject1100113311

Outcome measures

PrimaryComplete Clearance Rate

Number of AK Fields with 0 lesions

Time frame:
Week 12
Reported as:
Count of units · AK Fields
Complete Clearance Rate
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Complete Clearance Rate161510121915181844
SecondaryComplete Clearance Rate

Number of AK Fields with 0 Lesions

Time frame:
Week 8
Reported as:
Count of units · AK Fields
Complete Clearance Rate
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Complete Clearance Rate577713118942
SecondarySubject Satisfaction Score

Subject satisfaction score 1. = Excellent (very satisfied) 2. = Good (moderately satisfied) 3. = Fair (slightly satisfied) 4. = Poor (not satisfied at all)

Time frame:
Week 12
Reported as:
Count of units · AK Fields
Subject Satisfaction Score
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Excellent (very satisfied)151321211818151488
Good (moderately satisfied)810551097833
Fair (slightly satisfied)1111014477
Poor (not satisfied)110000001212
SecondaryBaseline AKCR

AK clearance rate (AKCR) for only those lesions present at Baseline

Time frame:
Baseline and Week 8
Reported as:
Mean · percentage cleared
Baseline AKCR
percentage clearedMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Baseline AKCR74.5 ± 24.1472.3 ± 30.1575.0 ± 27.0369.6 ± 31.485.4 ± 22.2683.4 ± 22.6386.1 ± 15.5980.6 ± 22.6140.6 ± 35.6634.4 ± 36.66
SecondaryBaseline AKCR

AK clearance rate for only those lesions present at Baseline

Time frame:
Baseline and Week 12
Reported as:
Mean · percentage cleared
Baseline AKCR
percentage clearedMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Baseline AKCR92.2 ± 16.2889.2 ± 19.9682.3 ± 22.3286.7 ± 16.4493.2 ± 13.0495.1 ± 10.496.3 ± 7.4994.8 ± 13.3440.9 ± 37.2443.1 ± 40.42
SecondaryPercent Change

Percent change in the total AK number as compared with Baseline

Time frame:
Baseline and Week 8
Reported as:
Mean · percent change
Percent Change
percent changeMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Percent Change-65.9 ± 28.4-68.6 ± 30.99-64.7 ± 32.32-63.4 ± 36.04-72.9 ± 29.58-69.6 ± 34.46-79.4 ± 17.3-74.2 ± 28.56-27.9 ± 47.29-13.8 ± 49.02
SecondaryPercent Change

Percent change in the total AK number as compared with Baseline

Time frame:
Baseline and Week 12
Reported as:
Mean · percent change
Percent Change
percent changeMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Percent Change-87.0 ± 22.52-87.3 ± 20.45-75.0 ± 32.35-80.0 ± 25.1-88.9 ± 21.36-87.4 ± 17.47-95.5 ± 10.16-92.6 ± 19.08-26.0 ± 50.29-18.5 ± 54.77
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
Baseline
Reported as:
Count of units · AK Fields
Hyperpigmentation
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 012121616161613131515
Grade 1101166119881213
Grade 22155133310
Grade 31000001121
Grade 40100111101
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
24-48 hours after PDT #1
Reported as:
Count of units · AK Fields
Hyperpigmentation
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 012121515141510101515
Grade 1111167111011111213
Grade 21165221210
Grade 31000002121
Grade 40100111101
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
2 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Hyperpigmentation
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 011111414161612121615
Grade 112128899881113
Grade 21155222320
Grade 31100002112
Grade 40000111100
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
8 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Hyperpigmentation
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 011111616161610101616
Grade 111116678991010
Grade 21155323311
Grade 31000001122
Grade 40100111100
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
12 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Hyperpigmentation
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 010101515191910101616
Grade 1121277881091011
Grade 21155001321
Grade 31000002122
Grade 40100111100
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
Baseline
Reported as:
Count of units · AK Fields
Hypopigmentation
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 016182021232420202526
Grade 18676545554
Grade 21100110000
Grade 300000001100
Grade 40000000000
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
24-48 hours after PDT #1
Reported as:
Count of units · AK Fields
Hypopigmentation
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 017182021222318182627
Grade 17676545543
Grade 21100111100
Grade 30000001100
Grade 40000000000
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
2 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Hypopigmentation
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 015172122212316162526
Grade 19765748854
Grade 21100010000
Grade 30000000000
Grade 40000001100
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
8 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Hypopigmentation
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 015172121181915152323
Grade 18666878866
Grade 21100110000
Grade 30000000000
Grade 40000001100
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
12 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Hypopigmentation
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 016181820212116162322
Grade 17597777778
Grade 21100000000
Grade 30000000000
Grade 40000001100
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
Baseline
Reported as:
Count of units · AK Fields
Erythema
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 012121616171616151515
Grade 11011881212991211
Grade 22133011234
Grade 31100000000
Grade 40000000000
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
5 minutes after PDT #1
Reported as:
Count of units · AK Fields
Erythema
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 0343322111212
Grade 13599246879
Grade 21513471212910108
Grade 34311812109511
Grade 40000001200
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
24-48 hours after PDT #1
Reported as:
Count of units · AK Fields
Erythema
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 0011100001112
Grade 100122302910
Grade 21114914691010108
Grade 31410138171212900
Grade 40032343400
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
2 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Erythema
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 09101414151512131313
Grade 113119109101191414
Grade 23343432333
Grade 30100000000
Grade 40000000000
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
8 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Erythema
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 012121618181716151414
Grade 110109778791010
Grade 22222221055
Grade 30000000000
Grade 40000000000
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
12 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Erythema
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 015141918201916171514
Grade 17878788789
Grade 21111110077
Grade 31100000000
Grade 40000000000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
Baseline
Reported as:
Count of units · AK Fields
Edema
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 025252727292926263030
Grade 10000000000
Grade 20000000000
Grade 30000000000
Grade 40000000000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
5 minutes after PDT #1
Reported as:
Count of units · AK Fields
Edema
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 020202323232622242928
Grade 13423512112
Grade 22111010000
Grade 30010002100
Grade 40000000000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
24-48 hours after PDT #1
Reported as:
Count of units · AK Fields
Edema
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 01318202017148132929
Grade 18433599501
Grade 23233436310
Grade 31111222300
Grade 40000000100
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
2 weeks after PDT #1
Reported as:
Count of units · AK Fields
Edema
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 025242525282824253030
Grade 10122001000
Grade 20000000000
Grade 30000000000
Grade 40000000000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
8 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Edema
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 024242727272724242929
Grade 10000000000
Grade 20000000000
Grade 30000000000
Grade 40000000000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
12 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Edema
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 024242727282824243030
Grade 10000000000
Grade 20000000000
Grade 30000000000
Grade 40000000000
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
Baseline
Reported as:
Count of units · AK Fields
Stinging/Burning
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 024242727292925252930
Grade 11100001110
Grade 20000000000
Grade 30000000000
Other pre-specifiedStinging/Burning

Immediately after PDT, the most intensive, acute perception of Stinging/Burning DURING treatment will be recorded. STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
During PDT #1
Reported as:
Count of units · AK Fields
Stinging/Burning
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 0121100002124
Grade 1914716555696
Grade 21391671517101200
Grade 320339711800
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
5 minutes after PDT #1
Reported as:
Count of units · AK Fields
Stinging/Burning
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 0697955572829
Grade 116141213161991121
Grade 232857411700
Grade 30000001100
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
24-48 Hours after PDT #1
Reported as:
Count of units · AK Fields
Stinging/Burning
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 098121376892828
Grade 1614811151691022
Grade 210363668600
Grade 30010000000
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
2 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Stinging/Burning
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 024242626282825253030
Grade 11111000000
Grade 20000000000
Grade 30000000000
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
8 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Stinging/Burning
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 024242727272723222829
Grade 10000001210
Grade 20000000000
Grade 30000000000
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
12 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Stinging/Burning
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 024242726272724243030
Grade 10001110000
Grade 20000000000
Grade 30000000000
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
Baseline
Reported as:
Count of units · AK Fields
Scaling & Dryness
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 019191818161617171919
Grade 1557812108788
Grade 21120131233
Grade 30001000000
Grade 40000000000
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
24-48 hours after PDT #1
Reported as:
Count of units · AK Fields
Scaling & Dryness
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 015151617161717162020
Grade 17777673678
Grade 21233423221
Grade 32110112111
Grade 40000110000
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
2 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Scaling & Dryness
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 016171616202120212223
Grade 187107543187
Grade 20014331200
Grade 31100001100
Grade 40000000000
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
8 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Scaling & Dryness
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 019202021222218192222
Grade 14365334343
Grade 20011222223
Grade 31100000011
Grade 40000000000
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
12 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Scaling & Dryness
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 023222322252420212323
Grade 10145333266
Grade 20000010111
Grade 31100001000
Grade 40000000000
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
Baseline
Reported as:
Count of units · AK Fields
Oozing/Vesiculation/Crusting
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 023242425292924242929
Grade 11021002200
Grade 21011000011
Grade 30100000000
Grade 40000000000
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
24-48 hours after PDT #1
Reported as:
Count of units · AK Fields
Oozing/Vesiculation/Crusting
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 018202123242520192929
Grade 14232214500
Grade 22222221111
Grade 31110000000
Grade 40000000000
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
2 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Oozing/Vesiculation/Crusting
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 023242526262724252828
Grade 11020211011
Grade 20001000011
Grade 31100000000
Grade 40000000000
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
8 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Oozing/Vesiculation/Crusting
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 023232525252623232626
Grade 10012211111
Grade 21110000022
Grade 30000000000
Grade 40000000000
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
12 Weeks after PDT #1
Reported as:
Count of units · AK Fields
Oozing/Vesiculation/Crusting
AK FieldsMN + ALA 25 Min 10 mWALA 25 Min 10 mWMN + ALA 25 Min 20 mWALA 25 Min 20 mWMN + ALA 60 Min 10mWALA 60 Min 10 mWMN + ALA 60 Min 20 mWALA 60 Min 20 mWMN + VEHVEH PDT
Grade 024242727282823232929
Grade 10000001100
Grade 20000000011
Grade 30000000000
Grade 40000000000

Adverse events

Collected over 3 months. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
ALA 25 Min 10 mW0/25 (0%)0/25 (0%)1/25 (4%)
ALA 25 Min 20 mW0/27 (0%)0/27 (0%)1/27 (3.7%)
ALA 60 Min 10 mW0/29 (0%)0/29 (0%)4/29 (13.8%)
ALA 60 Min 20 mW0/26 (0%)1/26 (3.8%)7/26 (26.9%)
VEH 60 Min 10 mW0/30 (0%)0/30 (0%)2/30 (6.7%)
Most frequent serious events
Most frequent serious events
EventALA 25 Min 10 mWALA 25 Min 20 mWALA 60 Min 10 mWALA 60 Min 20 mWVEH 60 Min 10 mW
unstable anginaCardiac disorders0/250/270/291/260/30
Most frequent other events
Most frequent other events
EventALA 25 Min 10 mWALA 25 Min 20 mWALA 60 Min 10 mWALA 60 Min 20 mWVEH 60 Min 10 mW
PainInjury, poisoning and procedural complications1/251/273/297/260/30
Upper respiratory tract infectionInfections and infestations0/250/271/290/262/30

Baseline characteristics

Age, Continuous
Age, Continuous(years)ALA 25 Min 10 mWALA 25 Min 20 mWALA 60 Min 10 mWALA 60 Min 20 mWVEH 60 Min 10 mWTotal
Mean66 ± 1064 ± 867 ± 866 ± 964 ± 1065 ± 9
Sex: Female, Male
Sex: Female, Male(Participants)ALA 25 Min 10 mWALA 25 Min 20 mWALA 60 Min 10 mWALA 60 Min 20 mWVEH 60 Min 10 mWTotal
Female8756329
Male1720242027108
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)ALA 25 Min 10 mWALA 25 Min 20 mWALA 60 Min 10 mWALA 60 Min 20 mWVEH 60 Min 10 mWTotal
Hispanic or Latino001001
Not Hispanic or Latino2527282630136
Unknown or Not Reported000000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)ALA 25 Min 10 mWALA 25 Min 20 mWALA 60 Min 10 mWALA 60 Min 20 mWVEH 60 Min 10 mWTotal
American Indian or Alaska Native000000
Asian000000
Native Hawaiian or Other Pacific Islander000000
Black or African American000000
White2527292630137
More than one race000000
Unknown or Not Reported000000
Skin Type
Skin Type(Participants)ALA 25 Min 10 mWALA 25 Min 20 mWALA 60 Min 10 mWALA 60 Min 20 mWVEH 60 Min 10 mWTotal
Type I - Burns easily, never tans322007
Type II - Burns easily, tans minimally101219142176
Type III - Burns moderately, tans gradually1211610948
Type IV - Burns minimally, tans well022206
08

Study locations

8 sites
  • UCSD Dermatology
    San Diego, California 92122, United States
  • Therapeutics Clinical Research
    San Diego, California 92123, United States
  • MOORE Clinical Research, Inc
    Brandon, Florida 33609, United States
  • Altman Dermatology Associates
    Arlington Heights, Illinois 60005, United States
  • Shideler Clinical Research Center
    Carmel, Indiana 46032, United States
  • The Indiana Clinical Trials Center, PC
    Plainfield, Indiana 46168, United States
  • Minnesota Clinical Study Center
    Fridley, Minnesota 55432, United States
  • Virginia Clinical Research, Inc.
    Norfolk, Virginia 23507, United States
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2016, a primary completion of Sep 2016 and a completion of Sep 2016. It does not say whether these dates are actual or estimated.

Results were first posted in Dec 2017, 1 year 3 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 14, 2015
First posted
Dec 16, 2015
Start
Mar 2016
Primary completionActual
Sep 12, 2016
CompletionActual
Sep 12, 2016
Results first posted
Dec 13, 2017
Last update
Jan 18, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 18, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02632110
Responsible party
Sponsor
First posted
Dec 16, 2015
Start date
Mar 2016
Primary completion
Sep 12, 2016
Completion
Sep 12, 2016
Results posted
Dec 13, 2017
Last update
Jan 18, 2018

Study contacts

Stuart Marcus, MD, PhD
study director · DUSA Pharmaceuticals, Inc.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Aminolevulinic Acid

Start the discussion